Xiaoyuan Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Physiology top 5%
- Adipose Tissue and Metabolism 14
- Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases 10
- Immunology top 10%
- Molecular Biology top 10%
- RNA Research and Splicing 12
- Bone Metabolism and Diseases 8
- Ubiquitin and proteasome pathways 7
- RNA modifications and cancer 7
- Co-authors
- Anthony W. FerranteMireille J. SerlieAlicja A. SkowronskiMarco van EijkStephen E FlahertyAlireza NomaniJonathan KrakoffWeidong Li
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)SHILAP Revista de lepidopterología (3 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Xiaoyuan Xu
82 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 402
- Physiology 522
- Epidemiology 621
- Immunology 376
- Molecular Biology 930
Countries citing papers authored by Xiaoyuan Xu
This map shows the geographic impact of Xiaoyuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Xu more than expected).
Fields of papers citing papers by Xiaoyuan Xu
This network shows the impact of papers produced by Xiaoyuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Xu. The network helps show where Xiaoyuan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoyuan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2021 | 9 | |
| 3 | 2020 | 30 | |
| 4 | A lipase-independent pathway of lipid release and immune modulation by adipocytesbreakdown → | 2019 | 275 |
| 5 | 2019 | 45 | |
| 6 | 2018 | 3 | |
| 7 | 2016 | 1 | |
| 8 | 2015 | 18 | |
| 9 | 2015 | 10 | |
| 10 | 2014 | 7 | |
| 11 | 2013 | 405 | |
| 12 | 2013 | 2 | |
| 13 | 2010 | 12 | |
| 14 | Impact of Alcohol Drinking on the Clinical Progression and Outcome of Patients with Chronic Hepatitis C | 2009 | 1 |
| 15 | 2008 | 43 | |
| 16 | Control evaluation in a LVoD system based on a peer-to-peer multicast scheme | 2007 | 1 |
| 17 | Clinical Observation of Therapeutic Effect of Compound Glycyrrhizin on SARS | 2003 | 13 |
| 18 | Findings of anti-HIV tests in persons infected by HCV after blood transfusion in one county of Hebei Province | 2003 | 1 |
| 19 | 2002 | 3 | |
| 20 | 2002 | 13 |
About Xiaoyuan Xu
Xiaoyuan Xu is a scholar working on Cancer Research, Molecular Biology and Biochemistry, having authored 85 papers that have together received 2.0k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (14 papers), RNA Research and Splicing (12 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Bone Metabolism and Diseases (8 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Ubiquitin and proteasome pathways (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (402 citations), Physiology (522 citations) and Epidemiology (621 citations). Xiaoyuan Xu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Anthony W. Ferrante, Mireille J. Serlie, Alicja A. Skowronski, Marco van Eijk, Stephen E Flaherty, Alireza Nomani, Jonathan Krakoff, Weidong Li, Jianyun Liu and Ann Marie Ocampo Francisco. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.